These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33376528)

  • 1. P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma.
    Wu Y; Peng Y; Guan B; He A; Yang K; He S; Gong Y; Li X; Zhou L
    Oncol Lett; 2021 Feb; 21(2):95. PubMed ID: 33376528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB.
    Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S
    Front Immunol; 2023; 14():1253586. PubMed ID: 37790935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant Prognostic Value of the Autophagy-Related Gene P4HB in Bladder Urothelial Carcinoma.
    Lyu L; Xiang W; Zheng F; Huang T; Feng Y; Yuan J; Zhang C
    Front Oncol; 2020; 10():1613. PubMed ID: 32903592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder.
    Wang X; Bai Y; Zhang F; Yang Y; Feng D; Li A; Yang Z; Li D; Tang Y; Wei X; Wei W; Han P
    Onco Targets Ther; 2020; 13():9543-9558. PubMed ID: 33061438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
    Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
    World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy-related gene
    Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X
    Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical analysis of novel prognostic transcription factors and immune-related gene signatures for bladder cancer via TCGA-based bioinformatic analysis.
    Deng Y; Hong X; Yu C; Li H; Wang Q; Zhang Y; Wang T; Wang X
    Oncol Lett; 2021 May; 21(5):344. PubMed ID: 33747201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis and bioinformatics analysis of P4HB expression levels in the prognosis of cancer patients.
    Wang F; Yu Z; Liu X; Hu F; Liu X; Fu X; Liu Y; Zou Z
    Pathol Res Pract; 2023 May; 245():154474. PubMed ID: 37119730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of RAC3 in bladder cancer predicts adverse clinical outcome and increased tumor immune response.
    Ou-Yang S; Liu JH; Wang QZ
    Int J Clin Exp Pathol; 2020; 13(12):2937-2949. PubMed ID: 33425095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
    He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
    Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoplasmic reticulum chaperone prolyl 4-hydroxylase, beta polypeptide (P4HB) promotes malignant phenotypes in glioma via MAPK signaling.
    Sun S; Kiang KMY; Ho ASW; Lee D; Poon MW; Xu FF; Pu JKS; Kan ANC; Lee NPY; Liu XB; Man K; Day PJR; Lui WM; Fung CF; Leung GKK
    Oncotarget; 2017 Sep; 8(42):71911-71923. PubMed ID: 29069756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of P4HB is correlated with poor prognosis in human clear cell renal cell carcinoma.
    Zhu Z; He A; Lv T; Xu C; Lin L; Lin J
    Cancer Biomark; 2019; 26(4):431-439. PubMed ID: 31640086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chaperone protein P4HB predicts temozolomide response and prognosis in malignant glioma.
    Sun S; Kiang KM; Leung GK
    Oncol Lett; 2022 Aug; 24(2):264. PubMed ID: 35765277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
    Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
    Front Immunol; 2023; 14():955949. PubMed ID: 37006317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HYAL3 as a potential novel marker of BLCA patient prognosis.
    Liu JP; Fang YT; Jiang YF; Lin H
    BMC Genom Data; 2022 Aug; 23(1):63. PubMed ID: 35945500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis.
    Lin Y; Li T; Li Z; Shen C; Wu Z; Zhang Z; Li Z; Yang S; Wang Z; Li P; Fu C; Guo J; Hu H
    Front Genet; 2023; 14():1097179. PubMed ID: 37091788
    [No Abstract]   [Full Text] [Related]  

  • 17. The Prognostic Significance of Proteasome 26S Subunit, Non-ATPase (PSMD) Genes for Bladder Urothelial Carcinoma Patients.
    Salah Fararjeh A; Al-Khader A; Al-Saleem M; Abu Qauod R
    Cancer Inform; 2021; 20():11769351211067692. PubMed ID: 34992336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer.
    Li H; Zhang Y; Zheng S
    Biomed Res Int; 2021; 2021():8530186. PubMed ID: 34926692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices.
    Pan S; Zhan Y; Chen X; Wu B; Liu B
    Front Oncol; 2019; 9():613. PubMed ID: 31334127
    [No Abstract]   [Full Text] [Related]  

  • 20. High expression of
    Lin B; Zhang T; Ye X; Yang H
    Oncol Lett; 2020 Sep; 20(3):2840-2854. PubMed ID: 32782602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.